Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1987-06-12
1990-05-15
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 260408, A61K 4902, A61K 4900
Patent
active
049256491
ABSTRACT:
Novel iodinated and radioiodinated 1,2-diacylglycerol analogues are biological reagents for studying the effect of diacylglycerols in the activation of protein kinase C. This calcium-requiring enzyme may be involved in tumor promotion by phorbol diesters and related compounds. Iodinated and radioiodinated 1,2-diacylglycerol analogues, in accordance with the invention, are useful as imaging agents, such as radiopaques and radiopharmaceuticals, and have the general formula: ##STR1## The triglycerol backbone structure is 1,2-disubstituted with one position being occupied by an iodine-containing substituent, preferably an amino-substituted-2,4,6-triiodophenyl aliphatic chain, such as iopanoic acid, or by a monoiodiphenyl aliphatic chain, such as (m-iodophenyl)propanoic acid. The other position may be substituted with saturated and unsaturated long and short aliphatic chains.
REFERENCES:
Weichert, J. et al. "Lipid Soluble Contrast Agents for Hepatic CT Imaging", Acs Meeting Abstract No. 29, Washington, DC 8/1983.
Counsell Raymond E.
Strawn Laurie
Maples John S.
The University of Michigan
LandOfFree
Radioiodinated diacylglycerol analogues and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioiodinated diacylglycerol analogues and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioiodinated diacylglycerol analogues and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-620495